Literature DB >> 19453567

Long-term changes in graft height after maxillary sinus floor elevation with different grafting materials: radiographic evaluation with a minimum follow-up of 4.5 years.

Steven A Zijderveld1, Engelbert A J M Schulten, Irene H A Aartman, Christiaan M ten Bruggenkate.   

Abstract

OBJECTIVE: To compare the vertical dimensional changes with regard to graft height in a long-term follow-up in patients treated with two different grafting materials used in maxillary sinus floor elevation procedures.
MATERIAL AND METHODS: Twenty consecutive patients were included. One group was grafted with autogenous bone from the mandible (chin area), and the other group was augmented with a 100% beta-tricalcium phosphate (beta-TCP). During a 4- to 5-year period, in each patient, at least five panoramic radiographs were made. These panoramic radiographs were used for morphometric measurements, at three different locations. The three locations were the first bone to implant contact at the distal side of the second most posterior implant (L1), halfway between this implant and the most posterior implant (L2) and the site 5 mm distal to the most posterior implant (L3). The measured vertical bone heights were evaluated to assess whether there was loss of height and, if so, whether the reduction in graft height occurred in an initial healing period or whether it was an ongoing process during the whole study period.
RESULTS: There is a statistically significant reduction of vertical bone height in time at all locations (P<0.001). The mean decrease of the total vertical height during the whole study period at the three different locations did not differ significantly for and between both grafting groups. Repeated measures analysis of variance showed that at location L1, the reduction in millimeters per month decreased in time (P=0.001). There was no difference between the grafting groups (P=0.958). Similar results were found on L2 (P=0.005). For L3, there also appeared to be a statistically significant difference in reduction in time in millimeters per month (P=0.004). There was no statistically significant difference in height reduction between locations L1, L2 and L3 for vertical bone height and graft height, respectively.
CONCLUSIONS: Both beta-TCP and mandibular bone grafts resulted in radiographic reduction of the vertical height over the 5-year period following maxillary sinus floor elevation. After an initial height reduction in the first 1.5 year, subsequent changes were minimal. No significant differences were observed between the two types of grafting material. There was no statistically significant difference in reduction between the three locations for vertical bone height and graft height, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453567     DOI: 10.1111/j.1600-0501.2008.01697.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  21 in total

1.  Efficacy of autogenous teeth for the reconstruction of alveolar ridge deficiencies: a systematic review.

Authors:  Ausra Ramanauskaite; D Sahin; R Sader; J Becker; F Schwarz
Journal:  Clin Oral Investig       Date:  2019-03-11       Impact factor: 3.573

2.  Long-Term Results after Placing Dental Implants in Patients with Papillon-Lefèvre Syndrome: Results 2.5-20 Years after Implant Insertion.

Authors:  Katrin Nickles; Mischa Krebs; Beate Schacher; Hari Petsos; Peter Eickholz
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

3.  Radiographic Analysis of Graft Dimensional Changes in Transcrestal Maxillary Sinus Augmentation: A Retrospective Study.

Authors:  Luca Comuzzi; Margherita Tumedei; Adriano Piattelli; Gianluca Tartaglia; Massimo Del Fabbro
Journal:  Materials (Basel)       Date:  2022-04-19       Impact factor: 3.748

4.  Evaluation of Three-Dimensional Volumetric Changes After Sinus Floor Augmentation with Mineralized Cortical Bone Allograft.

Authors:  Antoine Berberi; Lea Bouserhal; Nabih Nader; Rita Bou Assaf; Nayla Bassil Nassif; Joseph Bouserhal; Ziad Salameh
Journal:  J Maxillofac Oral Surg       Date:  2014-12-24

5.  Resorption of bone graft after maxillary sinus grafting and simultaneous implant placement.

Authors:  Young-Kyun Kim; Su-Gwan Kim; Bum-Su Kim; Kyung-In Jeong
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-06-27

6.  High-Resolution Three-Dimensional Computed Tomography Analysis of the Clinical Efficacy of Cultured Autogenous Periosteal Cells in Sinus Lift Bone Grafting.

Authors:  Shin Ogawa; Hideyuki Hoshina; Koh Nakata; Kazuho Yamada; Kohya Uematsu; Tomoyuki Kawase; Ritsuo Takagi; Masaki Nagata
Journal:  Clin Implant Dent Relat Res       Date:  2015-05-27       Impact factor: 3.932

7.  Long-term radiographic assessment of maxillary sinus floor augmentation using beta-tricalcium phosphate: analysis by cone-beam computed tomography.

Authors:  Tsuneji Okada; Toru Kanai; Noriko Tachikawa; Motohiro Munakata; Shohei Kasugai
Journal:  Int J Implant Dent       Date:  2016-04-01

8.  Ridge preservation using an in situ hardening biphasic calcium phosphate (β-TCP/HA) bone graft substitute-a clinical, radiological, and histological study.

Authors:  Ashish Kakar; Bappanadu H Sripathi Rao; Shashikanth Hegde; Nikhil Deshpande; Annette Lindner; Heiner Nagursky; Aditya Patney; Harsh Mahajan
Journal:  Int J Implant Dent       Date:  2017-06-22

9.  Effect of a Particulate and a Putty-Like Tricalcium Phosphate-Based Bone-grafting Material on Bone Formation, Volume Stability and Osteogenic Marker Expression after Bilateral Sinus Floor Augmentation in Humans.

Authors:  Christine Knabe; Doaa Adel-Khattab; Esther Kluk; Rainer Struck; Michael Stiller
Journal:  J Funct Biomater       Date:  2017-07-29

10.  Late-term healing in an augmented sinus with different ratios of biphasic calcium phosphate: a pilot study using a rabbit sinus model.

Authors:  Hyun-Chang Lim; Ji-Youn Hong; Jung-Seok Lee; Ui-Won Jung; Seong-Ho Choi
Journal:  J Periodontal Implant Sci       Date:  2016-02-22       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.